Skip to main content

Unfortunately we don't fully support your browser. If you have the option to, please upgrade to a newer version or use Mozilla Firefox, Microsoft Edge, Google Chrome, or Safari 14 or newer. If you are unable to, and need support, please send us your feedback.

We'd appreciate your feedback.Tell us what you think!

Elsevier
Publish with us

Committee & Speakers

Conference Chairs

Dorothee Dormann, Johannes Gutenberg University, Mainz, Germany

Fen-Biao Gao, University of Massachusetts Chan Medical School, USA

Aaron Gitler, University of Stanford, USA

Speakers

Keynote

Victor Ambros

Victor Ambros

University of Massachusetts Chan Medical School, USA

Read more about Victor Ambros

Session 1: Dysregulated RNA metabolism in neurological diseases

PF

Pietro Fratta

University of College London, UK

LT

Leslie Thompson

University of California, Irvine, USA

Session 2: Physiological functions of disease-linked RNA-binding proteins

JR

Joel Richter

University of Massachusetts Chan Medical School, USA

Gene Yeo

Gene Yeo

University of California, San Diego, USA

Read more about Gene Yeo

Session 3: Biomolecular condensates and their role in normal RNA processing and in disease

Simon Alberti

Simon Alberti

Dresden University of Technology, Germany

Read more about Simon Alberti
Roy Parker

Roy Parker

University of Colorado, Boulder, USA

Read more about Roy Parker

Session 4: Human genetics and genomics insights into neurological diseases

DC

Don Cleveland

University of California, San Diego, USA

Rosa Rademakers

Rosa Rademakers

VIB Center for Molecular Neurology, Antwerp, Belgium

Read more about Rosa Rademakers

Session 5: Structural insights into pathological RNA-binding proteins

MP

Magdalini Polymenidou

University of Zürich, Switzerland

Ben Ryskeldi-Falcon

Ben Ryskeldi-Falcon

MRC Cambridge, UK

Read more about Ben Ryskeldi-Falcon

Session 6: Toxicity of repeat RNAs and repeat proteins

DE

Dieter Edbauer

German Center for Neurodegenerative Diseases, Munich, Germany

LR

Laura Ranum

University of Florida, Gainesville, USA

Session 7: Novel biomarkers due to dysregulated RNA metabolism

MW

Michael Ward

National Institutes of Health, USA

Philip Wong

Philip Wong

Johns Hopkins University, USA

Read more about Philip Wong

Session 8: RNA-based therapeutics

AK

Anastasia Khvorova

University of Massachusetts Chan Medical School, USA

MS

Matthew Simon

Denali Therapeutics, USA

Discussion leaders

Session 1: Benjamin Wolozin, Boston University, USA Session 2: Albert La Spada, University of California Irvine, USA Session 3: Yi Lin, Tsinghua University, Beijing, China Session 4: Nancy Bonini, University of Pennsylvania, USA Session 5: Lin Guo, Thomas Jefferson University, USA Session 6: Jeffrey Rothstein, Johns Hopkins University, USA Session 7: Leonard Petrucelli, Mayo Clinic, USA Session 8: Dorothee Dormann, Johannes Gutenberg University, Mainz, Germany